EDITEL Polska S.A. (WSE:EDL)

Market Cap	18.00M
Revenue (ttm)	8.16M
Net Income (ttm)	902.57K
Shares Out	2.95M
EPS (ttm)	0.31
PE Ratio	19.95
Forward PE	n/a
Dividend	0.15 (2.46%)
Ex-Dividend Date	Jul 23, 2025

Volume	920
Average Volume	1,099
Open	6.05
Previous Close	6.10
Day's Range	5.90 - 6.05
52-Week Range	3.10 - 6.80
Beta	1.30
RSI	51.39
Earnings Date	Aug 12, 2025

About Revance Therapeutics

EDITEL Polska S.A. provides electronic data interchange solutions worldwide. The company provides Electronic Data integration (EDI), Web EDI, E-invoicing, and eCMR solutions. In addition, the company offers electronic invoicing platform, and introduction and training services. It serves automotive, foreign trade, government, DIY/Hepac, logistics, FMCG, healthcare/ pharma, and home appliance, and pharmaceutical sectors. The company was formerly known as Edison S.A. and changed its name to EDITEL Polska S.A. in July 2023. The company was founded ...

• Industry: Prepackaged Software
• Founded: 1980
• Employees: 26
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: EDL

Financial Performance

In 2024, EDITEL Polska's revenue was 7.99 million, an increase of 2.82% compared to the previous year's 7.78 million. Earnings were 1.01 million, a decrease of -10.98%.